ARCHIVES

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978